Announcements Trials
Browse Landscape

Phase

Phase 3 6Phase 2 3Phase NA 2Phase 2/3 1Phase 1/2 1Phase 1 1

Status

Unknown 1Terminated 1Recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 1Endocrine 1

Conditions

Intracranial Germ Cell CNS Tumor, Childhood 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Neuroendocrine 1

Interventions

Cisplatin 1514Carboplatin 1416Cyclophosphamide 1359Gemcitabine 1235Bevacizumab 1223Paclitaxel 1210Radiotherapy 1173Docetaxel 1079pembrolizumab 1026Oxaliplatin 934Capecitabine 898Fluorouracil 832Rituximab 729Doxorubicin 683Nivolumab 679Dexamethasone 665Etoposide 660Irinotecan 622Leucovorin 574Pemetrexed 508Drug Therapy 491Cetuximab 481Trastuzumab 467Cytarabine 466Magnetic Resonance Spectroscopy 457Filgrastim 446Prednisone 432Lenalidomide 409Specimen Handling 407Temozolomide 400

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Interventional × PE regimen × Clear all
NCT05124951 2021-11-18

The Efficacy of WVI in Patients With Localized Basal Ganglia Intracranial Germ Cell Tumors

Beijing Tiantan Hospital

Phase 2 Recruiting
150 enrolled

Intracranial Germ Cell CNS Tumor, Childhood

NCT04828395 2021-05-11

F&C

Tianjin Medical University Cancer Institute and Hospital

Phase 2 Unknown
65 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT03168594 2020-01-22

Study to Compare Irinotecan Combined With Cisplatin (IP) Versus Etoposide Combined With Cisplatin (EP) in Advanced and Metastatic Gastrointestinal Pancreatic and Esophageal Neuroendocrine Carcinoma

Peking University

Phase 2 Terminated
66 enrolled
Endocrine

Carcinoma, Neuroendocrine

Data powered by HemOnc (CC BY 4.0) Colophon âš¡